Found 5 resultsAuthor [ Title] Type Year
Filters: Author is Dekker, Cornelia L [Clear All Filters]
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.. Vaccine, 29(34), 5666-74. presented at the 2011 Aug 05. doi:10.1016/j.vaccine.2011.06.010. (2011).
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis, 197(5), 667-75. presented at the 2008 Mar 01. doi:10.1086/527489. (2008).
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis, 206(6), 811-20. presented at the 2012 Sep 15. doi:10.1093/infdis/jis427. (2012).
Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults. Hum Vaccin Immunother, 9(12), 2548-57. presented at the 2013 Dec. doi:10.4161/hv.26038. (2013).
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. PLoS One, 14(9), e0222178. presented at the 2019. doi:10.1371/journal.pone.0222178. (2019).